SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-032245
Filing Date
2023-09-11
Accepted
2023-09-11 15:30:13
Documents
18
Period of Report
2023-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 55630
2 ex4-01.htm EX-4.01 119325
3 ex5-01.htm EX-5.01 12455
4 ex10-01.htm EX-10.01 245827
5 ex10-02.htm EX-10.02 106910
6 ex99-01.htm EX-99.01 14239
7 ex99-01_001.jpg GRAPHIC 15019
  Complete submission text file 0001493152-23-032245.txt   863125

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE pali-20230911.xsd EX-101.SCH 3024
9 XBRL LABEL FILE pali-20230911_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE pali-20230911_pre.xml EX-101.PRE 22365
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3365
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 231247645
SIC: 2836 Biological Products, (No Diagnostic Substances)